Riversedge Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
520
+93
+22% +$42.9K 0.04% 226
2026
Q1
$205K Sell
427
-131
-23% -$67.1K 0.03% 203
2025
Q4
$313K Buy
558
+132
+31% +$74.9K 0.05% 135
2025
Q3
$219K Buy
+426
New +$186K 0.04% 176

Other funds holding MEDP

Riversedge Advisors's MEDP Position: Q2 2026 in Review

Riversedge Advisors increased its Medpace (MEDP) stake by 22% in Q2 2026, buying an estimated $42.9K and bringing the position to 520 shares worth $275K. The position accounts for 0.04% of the portfolio, ranked #226.

Riversedge Advisors first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $313K in Q4 2025. 210 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Riversedge Advisors held 520 shares of Medpace worth $275K as of Q2 2026.
  • Riversedge Advisors bought 93 Medpace shares in Q2 2026, an estimated $42.9K.
  • Medpace made up 0.04% of Riversedge Advisors's portfolio in Q2 2026, its #226 holding.
  • Riversedge Advisors first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Riversedge Advisors's Medpace position peaked at $313K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.